CARLSBAD, CA/SAN FRANCISCO - Verdezyne Inc., a synthetic biology company producing biobased chemicals, and Connell Bros. Co. LLC (CBC), a marketer and distributor of specialty chemicals in the Asia-Pacific region, announced an agreement for sales and distribution of Verdezyne's BIOLON™ DDDA (biobased dodecanedioic acid or DC12).

BIOLON DDDA will be produced at Verdezyne's commercial-scale plant in Malaysia and will be distributed in 17 countries throughout Asia-Pacific, including China, Japan and South Korea. The agreement assures CBC access to more than 10 percent of the expected plant capacity.

"This agreement with CBC reflects the strong interest in high-quality renewable chemicals such as our BIOLON DDDA," said E. William Radany, President and CEO of Verdezyne. "As one of the largest and most respected distributors of specialty chemicals in the Asia-Pacific region, CBC is a strong partner for us. We are sure this agreement marks the beginning of a long and mutually beneficial relationship."

Verdezyne's plant, which is expected to be completed in 2017, is anticipated to have the capacity to produce up to 9,000 metric tons of diacids, including BIOLON DDDA, annually.